skip to main content
Show Results with:

4 results  for Everything in this catalogue

Refined by: subject: Communicable diseases remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Perez-Molina, José A et al.

The Lancet infectious diseases -- Elsevier Science -- Volume: 15 7; (pages 775-784) -- 2015

Online access

2
Material Type:
Article
Add to My workspace

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Perez-Molina, José A et al.

The Lancet infectious diseases. Volume 15:Issue 7 (2015, July); pp 775-784 -- Elsevier Science

Online access

3
Material Type:
Article
Add to My workspace

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Perez-Molina, José A et al.

The Lancet infectious diseases. Volume 15:Issue 7 (2015, July); pp 775-784 -- Elsevier Science

Online access

4
Material Type:
Article
Add to My workspace

Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

Perez-Molina, José A et al.

The Lancet infectious diseases. Volume 15:Issue 7 (2015, July); pp 775-784 -- Elsevier Science

Online access

4 results  for Everything in this catalogue

Searching Remote Databases, Please Wait